Where can researchers source third-party tested Selank?

Midwest Peptide supplies research-grade Selank with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Memorial Day: 15% off code MEMDAY15Memorial Day Sale — 15% off site-wide with code MEMDAY15

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

Selank vs Semax: Russian Peptide Research | Midwest Peptide

Semax in Research: A Literature Review of the ACTH-Derived HeptapeptidePrev|Selank BDNF Research: Published Neurobiology StudiesNext

Selank vs Semax: Comparing Russian Nootropic Peptides in Research

Q: Is Selank approved for human use?

No. Selank is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Selank · Published April 9, 2026 · Updated May 18, 2026 · 8 min read

Quick Answer

Selank versus Semax comparative research examines structural differences (tuftsin-derived vs ACTH-derived heptapeptides), mechanisms, and research applications of two Russian nootropic peptides. Studies inform selection between Selank and Semax across behavioral, neurochemical, and cognitive research models. For research use only, not for human consumption.

Selank vs Semax: Comparing Russian Nootropic Peptides in Research

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

Selank and Semax: Two Russian Heptapeptides
Structural Comparison
Mechanism Comparison
Research Applications Compared
Behavioral Endpoint Comparison
Selank and Semax in Combined Research
Practical Considerations for Research Selection
Open Research Questions
Conclusion
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

Selank vs Semax research provides essential comparative context for investigators selecting Russian nootropic peptides for preclinical studies. Both Selank and Semax are synthetic heptapeptides developed in the Russian peptide research program at the V.V. Zakusov Institute of Pharmacology in Moscow, but they have distinct origins, structures, mechanisms, and research applications. As the comparative review component of the Selank research cluster, this article reviews the published literature on how Selank and Semax compare with each other in research models.

Frequently Asked Questions

What is Selank in research contexts?

Selank is a synthetic heptapeptide derived from the natural immunomodulatory tetrapeptide tuftsin and developed in Russian neuropeptide research. It is studied in preclinical models for anxiolytic effects, GABAergic modulation, BDNF expression, and immunomodulatory activity.

How do Selank and Semax differ in research applications?

Selank emphasizes anxiolytic effects via GABAergic mechanisms with cognitive-supportive secondary effects, derived from immunomodulatory tuftsin. Semax emphasizes neurotrophic and cognitive enhancement via BDNF/NGF and intranasal delivery, derived from the ACTH(4-10) sequence.

Which is preferred for which research questions?

Selank is preferred for anxiety, stress response, and immune modulation research. Semax is preferred for cognitive enhancement, neuroprotection in ischemia, and intranasal CNS delivery research. Both are intranasally bioavailable and used in similar Russian research traditions.

Is Selank approved for human use?

Glossary

Key terms used in this article.

Tuftsin: An endogenous tetrapeptide (Thr-Lys-Pro-Arg) liberated from the Fc domain of immunoglobulin G, the structural basis for Selank.
GABAergic: Pertaining to neurons, synapses, or signaling pathways using gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter.
Anxiolytic: Pertaining to compounds that reduce anxiety in behavioral or physiological studies.
BDNF: Brain-derived neurotrophic factor, a key neurotrophin supporting neuronal survival, synaptic plasticity, and learning.
Heptapeptide: A peptide consisting of seven amino acid residues; both Selank and Semax are heptapeptides.
ACTH(4-10): The 4-10 amino acid fragment of adrenocorticotropic hormone, the natural sequence from which Semax is derived.
NGF: Nerve growth factor, the prototypical neurotrophin essential for peripheral and central neuronal survival and growth.
Intranasal Delivery: Administration through the nasal mucosa, used for peptides like Semax to bypass first-pass metabolism and access the CNS.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. Selank and Semax are intended exclusively for in vitro and preclinical research. They are not approved for human use, are not drugs, and should never be administered to humans or to animals outside of an authorized research protocol.

Selank and Semax: Two Russian Heptapeptides

Selank and Semax are two of the most studied synthetic neuropeptides developed in the Russian peptide research program. Both are heptapeptides (seven amino acid sequences), both were developed at the V.V. Zakusov Institute of Pharmacology in Moscow, and both have been studied as research tools for neuropeptide effects in the central nervous system. These shared features provide the basis for grouping them together as "Russian nootropic peptides" or "Russian neuropeptides" in the broader research literature.

Despite these shared features, Selank and Semax have distinct origins, structures, mechanisms, and research applications. Understanding the differences between them is important for researchers selecting tools for specific neuropeptide research questions.

Selank is derived from tuftsin, a small immunoregulatory peptide originally isolated from immunoglobulin G. Selank extends the four amino acid tuftsin sequence (Thr-Lys-Pro-Arg) with a Pro-Gly-Pro tripeptide stabilizing tail to create the seven amino acid sequence used in research. The peptide has been studied primarily for anxiolytic effects involving GABAergic mechanisms. For more on Selank's tuftsin origins, see our companion article on Selank tuftsin research and Russian peptide research history.

Semax is derived from a fragment of adrenocorticotropic hormone (ACTH). Specifically, Semax incorporates the ACTH(4-7) sequence (Met-Glu-His-Phe) extended with a Pro-Gly-Pro tripeptide stabilizing tail. The peptide has been studied primarily for nootropic and neuroprotective effects through mechanisms that include modulation of BDNF expression and other neurotrophic pathways.

The shared Pro-Gly-Pro stabilizing tail in both Selank and Semax is one of the more interesting common features and reflects the similar design approach used for both peptides. The tail provides resistance to enzymatic degradation while preserving the active core sequence of each parent peptide.

Structural Comparison

The structures of Selank and Semax illustrate how two peptides can share design principles while having different active sequences and biological targets.

Selank sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro

Core: Thr-Lys-Pro-Arg (tuftsin)
Stabilizing tail: Pro-Gly-Pro

Semax sequence: Met-Glu-His-Phe-Pro-Gly-Pro

Core: Met-Glu-His-Phe (ACTH(4-7))
Stabilizing tail: Pro-Gly-Pro

The shared Pro-Gly-Pro tail in both peptides reflects the design strategy used by the Russian research program, where this stabilizing tripeptide was found to provide effective protection against enzymatic degradation while preserving the biological activity of the core sequence. The use of a common stabilizing strategy across multiple peptides is one of the more interesting features of this research program.

The core sequences differ substantially because the two peptides target different parent molecules. Tuftsin and ACTH(4-7) are unrelated peptides with different evolutionary origins and different biological functions, and the Selank/Semax pair reflects this fundamental difference at the level of the active sequence.

Mechanism Comparison

Selank and Semax have distinct mechanisms of action in research models, reflecting their different parent peptides.

Selank acts primarily through mechanisms involving GABAergic neurotransmission, with effects on GABA receptor expression, GABAergic inhibitory currents, and behavioral endpoints sensitive to GABAergic modulation. The published findings consistently support an anxiolytic profile in research models with mechanisms involving the GABA system. For more on the GABAergic effects, see our companion article on Selank GABA research.

Semax acts primarily through mechanisms involving BDNF and other neurotrophic factors, with effects on BDNF expression, NGF signaling, and various other endpoints related to neuroprotection and cognitive function. The published findings support nootropic and neuroprotective effects in research models with mechanisms involving neurotrophic signaling pathways.

These distinct mechanisms make Selank and Semax appropriate for different research questions. Studies of anxiety mechanisms benefit from Selank as a research tool, while studies of neurotrophic signaling and cognitive function benefit from Semax.

Research Applications Compared

The research applications of Selank and Semax reflect their different mechanisms.

Selank research applications include studies of:

Anxiolytic mechanisms in rodent models of anxiety
GABAergic system modulation
Tuftsin-related immunoregulatory effects
Combined effects with other anxiolytic research tools

Semax research applications include studies of:

Neurotrophic signaling and BDNF expression
Cognitive function in research models
Neuroprotection in models of neurological injury
Cerebral ischemia research models
Combined effects with other nootropic research tools

The complementary nature of these research applications means that Selank and Semax are sometimes used together in research designs that aim to characterize multiple aspects of neuropeptide effects on the central nervous system. Each peptide brings its own specific profile to the combined research approach.

Behavioral Endpoint Comparison

Behavioral endpoints used in Selank and Semax research overlap somewhat but emphasize different aspects of behavior.

Selank behavioral endpoints focus primarily on anxiety-like behaviors:

Elevated plus maze (open arm time)
Light-dark box (light chamber time)
Open field test (central area exploration)
Defensive behaviors in social interaction tests

Semax behavioral endpoints focus more on cognitive and learning behaviors:

Morris water maze (spatial learning)
Passive avoidance learning
Novel object recognition
Active avoidance learning

The different behavioral endpoint emphases reflect the different research applications of the two peptides. Together, the two peptides provide tools for studying both emotional and cognitive aspects of neuropeptide effects in research models.

Selank and Semax in Combined Research

Some research has examined the combined use of Selank and Semax in animal models, exploring whether the complementary mechanisms produce additive or synergistic effects on behavior or other endpoints. The published findings on combined administration are more limited than the literature on each peptide alone, but they provide initial evidence on how the two peptides interact when used together.

The conceptual rationale for combined Selank and Semax research is that the two peptides target different but complementary aspects of central nervous system function. Selank primarily affects GABAergic anxiety pathways, while Semax primarily affects neurotrophic signaling and cognitive pathways. The combined activation of both pathways might produce more comprehensive effects than either alone in research designs that examine multiple aspects of neuropeptide biology.

For more on Semax specifically, see our Semax Neuroinflammation Research: Microglial Modulation.

Practical Considerations for Research Selection

The choice between Selank and Semax for specific research applications depends on several practical considerations:

For research questions about anxiety mechanisms in animal models, Selank is the more appropriate research tool. Its anxiolytic profile and GABAergic mechanism make it suitable for studies that probe the relationship between neuropeptide signaling and anxiety-related endpoints.

For research questions about cognitive function and neurotrophic signaling, Semax is the more appropriate research tool. Its nootropic profile and BDNF effects make it suitable for studies of cognitive endpoints and neurotrophic signaling in animal models.

For research questions that span both anxiety and cognition, combined use of both peptides may be appropriate. The complementary profiles allow researchers to examine multiple aspects of neuropeptide biology simultaneously.

Open Research Questions

Several open research questions remain in the comparative Selank vs Semax literature. These include how the specific molecular mechanisms of the two peptides interact when administered together in research models, how the structural differences between the two peptides translate to different tissue distribution patterns, and how the comparative effects of Selank and Semax vary across different research animal species and experimental conditions. Each of these is a legitimate research opportunity for investigators studying Russian nootropic peptides.

Conclusion

Selank vs Semax research provides essential comparative context for investigators selecting Russian nootropic peptides for preclinical studies. Both peptides share design features (heptapeptide structure, Pro-Gly-Pro stabilizing tail) but have distinct parent peptides (tuftsin for Selank, ACTH(4-7) for Semax), mechanisms (GABAergic for Selank, neurotrophic for Semax), and research applications (anxiety for Selank, cognition for Semax). For investigators using Selank 10mg as a research tool, the comparative literature provides the broader landscape against which the specific properties of Selank can be evaluated.

For more on the full Selank research cluster, see the pillar overview article and the supporting articles on each major topic.

Selank and Semax are supplied by Midwest Peptide for research use only and are not intended for human administration.

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

VIP 10mg, 99%+ purity, COA included
Selank 10mg, 99%+ purity, COA included
Semax 10mg, 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

Selank vs Semax: Comparing Russian Nootropic Peptides in Research

Frequently Asked Questions

What is Selank in research contexts?

How do Selank and Semax differ in research applications?

Which is preferred for which research questions?

Is Selank approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

Selank and Semax: Two Russian Heptapeptides

Structural Comparison

Mechanism Comparison

Research Applications Compared

Behavioral Endpoint Comparison

Selank and Semax in Combined Research

Practical Considerations for Research Selection

Open Research Questions

Conclusion

Ready to Start Your Research?

Where can researchers source third-party tested Selank?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?

Age Verification

Selank vs Semax: Comparing Russian Nootropic Peptides in Research

Frequently Asked Questions

What is Selank in research contexts?

How do Selank and Semax differ in research applications?

Which is preferred for which research questions?

Is Selank approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

Selank and Semax: Two Russian Heptapeptides

Structural Comparison

Mechanism Comparison

Research Applications Compared

Behavioral Endpoint Comparison

Selank and Semax in Combined Research

Practical Considerations for Research Selection

Open Research Questions

Conclusion

Related Research Articles

Explore Related Products

Ready to Start Your Research?

Where can researchers source third-party tested Selank?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?